Clinical Trial Update: Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effects of SGLT2 inhibition on myocardial insulin sensitivity in patients with type 2 diabetes mellitus and stable coronary arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Andrea Giaccari | Conditions: Type2 Diabetes Mellitus, Stable Coronary Artery Disease | Phase 3 | Status: UNKNOWN